2 completed, 1 unknown. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Valentin Fuster: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FREEDOM COVID-19 Anticoagulation Strategy Enoxaparin, Apixaban - COVID-19, SARS-CoV-2 | Phase 4 | Completed | Valentin Fuster | 3460 | 2020-09-08 | 2023-03-16 |
| Promoting Heart Health in Preschool Children Children-Multicomponent intervention - Cardiovascular Health | Phase 3 | Completed | Valentin Fuster | 2279 | 2009-07-01 | 2017-01-09 |
| Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) Coronary Artery Bypass Graft, Percutaneous Coronary Intervention - Cardiovascular Diseases, Coronary Disease | Phase 3 | Unknown | Valentin Fuster | 1900 | 2004-04-01 | 2017-02-06 |
COVID-19 (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Pathologic Complete Response (1)
Coronary Artery Bypass (1) · Enoxaparin (1) · Percutaneous Coronary Intervention (1) · apixaban (1)
Colombia (2) · United States (2) · Brazil (1) · India (1) · Mexico (1)
Anu Lala, MD (1)
PMID 23067919, PMID 23121323, PMID 23277307, PMID 23500281, PMID 24129463, PMID 25236509, PMID 28081820, PMID 30428398, PMID 30522646, PMID 35241226, PMID 35422242, PMID 36889611
U01HL071988 (1)